手术切除联合射频消融治疗结肠癌肝转移疗效分析

doi:10.3969/j.issn.1672-5069.2016.03.018

Abstract

Abstract: Objective To investigate the efficacy of radiofrequency ablation after resection of colorectal caicinomain patients with liver metastases. Methods 17 patients with colorectal liver metastases had radical operation and hepatolobectomy and 12 had radical operation and radiofrequency ablation （RFA） from January 2008 to March 2014 in our series. Their clinical materials was retrospectively analyzed， and the survival curve was drawn by the Kaplan Meier. Results All the patients in radical operation and hepatolobectomy died within 20 months after surgery，and the average survival time was （13.412±0.912） months. The patients receiving RFA was followed-up for 6 to 28 months，and the average expected survival time was（18.496±2.139） months，which was significantly longer than in hepatolobectomy group（P<0.05）. Conclusion The radical operation and radiofrequency ablation for treating colorectal liver metastases is feasible，safe and effective， and it can obviously prolong the patient's survivals.

Key words: Liver metastases, Colorectal cancer, Radical operation, Radiofrequency ablation

An Yongde,GuoYamin,Fan Longxin. Efficacy of radiofrequency ablation after resection of colorectal caicinomain patients with liver metastases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 327-330.

References

[1] 刘金有. MRI诊断肝转移瘤的价值探讨.实用肝脏病杂志， 2011，14（1）:42-44.
[2] 许永华，徐敬慈，杨利霞，等. 应用MRI弥散成像表观弥散系数监测肝转移瘤化疗疗效研究.实用肝脏病杂志，2012，15（5）: 421-423.
[3] 顾晋，王林. 美国结直肠外科医师协会结肠癌治疗规范（2012版）精要及解读.中华胃肠外科杂志，2012，15（10）:997-999.
[4] Wang CC，Li J. An update on chemotherapy of colorectal liver metastases. World J Gastroenterol，2012，18（1）:25-33.
[5] Munene G，Parker RD，Shaheen AA，et al. Disparitiesin the surgical treatment of colorectal liver metastases. J Natl Med Assoc，2013，105（2）:128-137.
[6] 黄建钊，刘江伟，孙倩，等. 射频消融与手术切除治疗肝癌的疗效比较.广东医学，2012，33（13）:1991-1993.
[7] Xu J，Qin X，Wang J，et al. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol，2011，137（9）:1379-1396.
[8] 王新团，耿智敏，工华. 一期切除结直肠癌并发肝转移癌的临床应用. 实用肝脏病杂志，2015，18（4）:422-423.
[9] 葛勇胜，马金良，芙卫东，等. 经皮联合开腹微波消融术治疗多发危险部位肝脏转移瘤疗效分析.实用肝脏病杂志，2015，18（3）:233-236.
[10] 李双生，吕维富，张止峰，等. 消化道肿瘤肝转移介入治疗的临床应用及预后分析. 实用肝脏病杂志，2008，11（6）:388-390.
[11] Cucchetti A，Piscaglia F，Cescon M，et al. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol，2013，19（26）:4106-4118.
[12] Sainani NI，Gervais DA，Mueller PR，et al. Imaging after percutane.ous radiofrequency ablation of hepatic tumors:Part 2，Abnormal findings. AJR，2013，200（1）:194-204.
[13] Solbiati L，Ahmed M，Cova L，et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology，2012，265（3）:958-968.
[14] 张跃伟. 微创介入治疗肝癌对机体免疫功能影响的研究现状与展望. 实用肝脏病杂志，2014，17（3）:231-234.
[15] 李刚，寸英丽，杨丽春. 肝癌患者射频消融后血清Th1、Th2型细胞因子的变化.肝胆胰外科杂志，2010，22（2）:94-96.
[16] 杜清华，李霄，王振东，等. 肝癌射频消融与手术切除对机体抗肿瘤免疫状态的影响.安徽医药，2010，14（11）:1317-1319.
[17] 张志刚，张跃伟. 肝癌微创治疗对机体T淋巴细胞亚群影响的研究现状. 中华肿瘤防治杂志，2012，19（12）:609-612.
[18] Xia JZ，Xie FL，RanLF，et al. High-intensity focused ultra-sound ablation activates autologous tumor-specific_cyotoxic T lymphocytes.Ultrasound Med Biol，2012，38（8）:1363-1371.
[19] Minami Y，Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer:a literature review. Gut Liver，2013，7（1）:1-6.
[20] Ungureanu BS，Sandulescu L，Surlin V，et al. Surgical hepatic resection vs. ultrasonographic guided radiofrequency ablation in colorectal liver metastases:what should we choose Med Ultrason， 2014，16（2）:145-151.
[21] Snoeren N，Nijkamp MW，Berendsen T，et al. Multipolar radiofrequency ablation for colorectal liver metastases close to major hepatic vessels.Surgeon，2015，13（2）:77-82.
[22] Meriggi F，Bertocchi P，Zaniboni A. Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg，2013，27（5）:138-145.

Efficacy of radiofrequency ablation after resection of colorectal caicinomain patients with liver metastases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.
[2]	Wang Hua, Zhao Yaning.. Efficacy and safety of sorafenib in the treatment of patients with advanced primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 936-939.
[3]	Ye Xuan, Zhang Peng.. Efficacy of microwave ablation combined with transcatheter arterial chemoembolization in treatment of patients with hepatic metastasis from colorectal cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 955-958.
[4]	Hu Hongsheng, Sun Shaohua, Shen Feng, et al.. Efficacy of radiofrequency ablation combined with DC-CIK in the treatment of patients with advanced hepatocellular carcinoma and its effect on the quality of life [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 757-760.
[5]	Wu Quanlin, He Yaopeng. Efficacy of ERCP-guided radiofrequency ablation combined with chemotherapy in treatment of patients with cholangiocarcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 537-540.
[6]	Shen Yunzhi, Bai Yu, Lyu Chengyu, et al. Efficacy of transhepatic arterial chemoembolization and radiofrequency ablation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 475-476.
[7]	Liu Dayong, Yang Guanghua, Lu Zhaomin. Efficacy of transcatheter arterial chemoembolization combined with radiofrequency ablation and Addie injection in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 261-264.
[8]	Jiang Haitao, Zhang Yanmei, Fan Lu. Dynamic enhanced CT manifestation of liver metastases in patients with colorectal cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 125-126.
[9]	Xu Yan, Shi Cuicui, Fan Jiangao. What role the nonalcoholic fatty liver disease play in carcinogenesis of colorectal cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 149-152.
[10]	Wu Jinfeng,Bai Guodong,Cheng Rong. Combination of TACE and ultrasound-guided radiofrequency ablation in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 766-768.
[11]	Cao Guangcai，Bai Jiangjiang，Qi Wenhai，et al.. Efficacy of Antike capsule given after ultrasound-guided radiofrequency ablation under guidance of real time virtual sonography navigation system in the treatment of patients with hepatic rectal cancer metastases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 575-579.
[12]	Zhang Wei, Chen Gang, Sun Mimi, et al.. Clinical efficacy of TACE and radiofrequency ablation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 472-476.
[13]	Wang Jinbang, Zhuang Jing, Liu Yonggang, et al.. Laparoscopic hepatectomy in treatment of patients with hepatic metastases arrived from colorectal cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 500-501.
[14]	Yu Hongxing Chen Ying Liu Zipeng, et al.. Comparison of ultrasound-guided percutaneous laser ablation and radiofrequency ablation for the treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 320-323.
[15]	Wu Zhenguo, Chen Yongyong, Li Nan. Clinical efficacy of radiofrequency ablation combined with TACE in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 324-327.